Paulo Carvalho

788 total citations
38 papers, 623 citations indexed

About

Paulo Carvalho is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Paulo Carvalho has authored 38 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Pharmacology. Recurrent topics in Paulo Carvalho's work include Computational Drug Discovery Methods (10 papers), Research on Leishmaniasis Studies (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Paulo Carvalho is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Research on Leishmaniasis Studies (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Paulo Carvalho collaborates with scholars based in United States, Brazil and Argentina. Paulo Carvalho's co-authors include Mitchell A. Avery, Elizabeth Igne Ferreira, Ikhlas A. Khan, Bonnie A. Avery, Daneel Ferreira, Zulfıqar Ali, Lie Li, Alex Gutterres Taranto, Amar G. Chittiboyina and Cammi Thornton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Paulo Carvalho

35 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paulo Carvalho United States 15 225 180 114 111 90 38 623
Wilson Cardona Chile 15 161 0.7× 272 1.5× 109 1.0× 90 0.8× 80 0.9× 41 640
Carmen Lategan South Africa 20 282 1.3× 454 2.5× 167 1.5× 190 1.7× 67 0.7× 27 993
Eduardo F. Oliveira Portugal 9 423 1.9× 123 0.7× 32 0.3× 121 1.1× 81 0.9× 12 985
Jean Fotie United States 15 246 1.1× 278 1.5× 66 0.6× 172 1.5× 70 0.8× 37 654
Abraham Wube Austria 14 304 1.4× 181 1.0× 32 0.3× 181 1.6× 117 1.3× 16 687
Danilo D. Rocha Brazil 16 229 1.0× 197 1.1× 30 0.3× 61 0.5× 115 1.3× 30 634
Michael J. C. Buckle Malaysia 18 221 1.0× 266 1.5× 74 0.6× 122 1.1× 144 1.6× 26 754
Hiroshi Araya Japan 19 293 1.3× 137 0.8× 54 0.5× 224 2.0× 172 1.9× 63 872
Albert Ndakala Kenya 17 314 1.4× 356 2.0× 56 0.5× 199 1.8× 61 0.7× 38 783
Daniel P. Demarque Brazil 15 341 1.5× 115 0.6× 68 0.6× 232 2.1× 83 0.9× 36 847

Countries citing papers authored by Paulo Carvalho

Since Specialization
Citations

This map shows the geographic impact of Paulo Carvalho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulo Carvalho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulo Carvalho more than expected).

Fields of papers citing papers by Paulo Carvalho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paulo Carvalho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulo Carvalho. The network helps show where Paulo Carvalho may publish in the future.

Co-authorship network of co-authors of Paulo Carvalho

This figure shows the co-authorship network connecting the top 25 collaborators of Paulo Carvalho. A scholar is included among the top collaborators of Paulo Carvalho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paulo Carvalho. Paulo Carvalho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliveira, Tiago Alves de, Eduardo Habib Bechelane Maia, Daniel Luciano Falkoski, et al.. (2025). Silodosin as a Novel Inhibitor of Acetylcholinesterase, Butyrylcholinesterase, and BETA-Secretase 1: In Vitro and In Silico Studies. ACS Omega. 10(41). 48887–48899.
2.
3.
Oliveira, Tiago Alves de, Alisson Marques da Silva, Alex Gutterres Taranto, et al.. (2023). Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach. Pharmaceuticals. 16(12). 1657–1657. 5 indexed citations
4.
Oliveira, Tiago Alves de, Eduardo Habib Bechelane Maia, Letícia C. Assis, et al.. (2022). Evaluation of Docking Machine Learning and Molecular Dynamics Methodologies for DNA-Ligand Systems. Pharmaceuticals. 15(2). 132–132. 14 indexed citations
5.
Carvalho, Paulo, et al.. (2022). Identification of potential human beta-secretase 1 inhibitors by hierarchical virtual screening and molecular dynamics. Journal of Biomolecular Structure and Dynamics. 41(10). 4560–4574. 4 indexed citations
6.
Ferreira, Gláucio Monteiro, et al.. (2018). Identification, Characterization and Molecular Modelling Studies of Schistosoma mansoni Dihydrofolate Reductase Inhibitors: From Assay Development to Hit Identification. Current Topics in Medicinal Chemistry. 18(5). 406–417. 3 indexed citations
7.
Osman, Ahmed, Khaled M. Elokely, Vivek Yadav, et al.. (2017). Bioactive products from singlet oxygen photooxygenation of cannabinoids. European Journal of Medicinal Chemistry. 143. 983–996. 13 indexed citations
8.
Artifon, Everson L.A., et al.. (2014). Endoscopic ultrasound hemostasis techniques.. PubMed. 34(2). 155–60.
9.
Carvalho, Paulo, et al.. (2013). Click chemistry decoration of amino sterols as promising strategy to developed new leishmanicidal drugs. Steroids. 79. 28–36. 28 indexed citations
10.
Gul, Waseem, et al.. (2009). 5-{[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-Trimethylperhydro-3,12-epoxy-1,2-dioxepino[4,3-i]isochromen-10-yl]oxymethyl}benzene-1,3-diol. Acta Crystallographica Section E Structure Reports Online. 65(2). o358–o359. 1 indexed citations
11.
Li, Ze, E. Blake Watkins, Hua Liu, et al.. (2008). 1,3-Diaxially Substituted trans-Decalins: Potential Nonsteroidal Human Progesterone Receptor Inhibitors. The Journal of Organic Chemistry. 73(19). 7764–7767. 19 indexed citations
12.
13.
Taranto, Alex Gutterres, Paulo Carvalho, & Mitchell A. Avery. (2008). QM/QM studies for Michael reaction in coronavirus main protease (3CLPro). Journal of Molecular Graphics and Modelling. 27(3). 275–285. 13 indexed citations
14.
Zhu, Shiqian, Lie Li, Cammi Thornton, et al.. (2008). Simultaneous determination of benzo[a]pyrene and eight of its metabolites in Fundulus heteroclitus bile using ultra-performance liquid chromatography with mass spectrometry. Journal of Chromatography B. 863(1). 141–149. 47 indexed citations
15.
Ali, Zulfıqar, Daneel Ferreira, Paulo Carvalho, Mitchell A. Avery, & Ikhlas A. Khan. (2008). Nigellidine-4-O-sulfite, the First Sulfated Indazole-Type Alkaloid from the Seeds of Nigella sativa. Journal of Natural Products. 71(6). 1111–1112. 56 indexed citations
16.
Li, Lie, et al.. (2007). Analysis of CoQ10 in rat serum by ultra-performance liquid chromatography mass spectrometry after oral administration. Journal of Pharmaceutical and Biomedical Analysis. 46(1). 137–142. 15 indexed citations
17.
Labadié, Guillermo R., Paulo Carvalho, Sanjay Batra, et al.. (2005). Solid-Supported Parallel Synthesis of Hydroxybenzylamine Libraries Possessing Antileishmial Activity. Medicinal Chemistry Research. 14(6). 332–346. 1 indexed citations
18.
McLuskey, Karen, Federica Gibellini, Paulo Carvalho, Mitchell A. Avery, & William N. Hunter. (2004). Inhibition ofLeishmania majorpteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary complex. Acta Crystallographica Section D Biological Crystallography. 60(10). 1780–1785. 32 indexed citations
19.
Carvalho, Paulo, et al.. (2003). Synthesis and in vitro Evaluation of Potential Anti‐Leishmanial Targeted Drugs of Pyrimethamine. Journal of Pharmaceutical Sciences. 92(10). 2109–2116. 7 indexed citations
20.
Carvalho, Paulo & Elizabeth Igne Ferreira. (2001). Leishmaniasis phytotherapy. Nature's leadership against an ancient disease. Fitoterapia. 72(6). 599–618. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilson Cardona Breakdown of academic impact, for papers by Carmen Lategan Breakdown of academic impact, for papers by Eduardo F. Oliveira Breakdown of academic impact, for papers by Jean Fotie Breakdown of academic impact, for papers by Abraham Wube Breakdown of academic impact, for papers by Danilo D. Rocha Breakdown of academic impact, for papers by Michael J. C. Buckle Breakdown of academic impact, for papers by Hiroshi Araya Breakdown of academic impact, for papers by Albert Ndakala Breakdown of academic impact, for papers by Daniel P. Demarque
Rankless by CCL
2026